Director Steven Mihaylo Files to Sell $17.3 Million in Crexendo Stock
CXDO sits 77% above its 52-week low of $5.13 on elevated volume (2.3× avg).
Summary
A Director at Crexendo, Steven G. Mihaylo, has filed a Form 144 to sell approximately $17.3 million worth of common stock, adding to a recent trend of significant insider sales.
Key Events · Ownership and Investor Activity · CXDO
-
Director Files Intent to Sell
Steven G. Mihaylo, a Director of Crexendo, Inc., has filed a Form 144 indicating his intent to sell 1,673,385 shares of common stock.
-
Substantial Proposed Sale Value
The proposed sale has an approximate market value of $17,357,953.00, making it a significant transaction.
-
Part of Ongoing Insider Distribution
This filing follows a pattern of substantial insider selling over the last 90 days, with net insider sales totaling nearly $25 million, and several other officers filing Form 144s or executing sales.
Analysis · CXDO · Technology
This Form 144 filing indicates a Director's intent to sell a substantial amount of company stock, representing a significant portion of the company's market capitalization. This proposed sale, valued at over $17 million, is a major contribution to the ongoing pattern of insider distribution observed over the past 90 days, which has seen net insider sales of nearly $25 million. Such a large intent to sell from a director can be interpreted as a lack of confidence in the company's near-term prospects and could exert downward pressure on the stock.
How filings like this one have moved
In the 30 days to Sep 23, 2026, 39.7% of the 353 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.30%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CXDO was trading at $9.09 on NASDAQ in the Technology sector, with a market capitalization of approximately $297.6M. The 52-week trading range was $5.13 to $11.23. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.